Issue of shares

Summary by AI BETAClose X

Caspian Sunrise PLC has issued 2,121,210 new ordinary shares at an issue price of 5p per share as bonus payments to non-board members. Following admission to AIM, expected around December 5, 2025, the Company's total issued share capital will be 2,356,306,042 ordinary shares, which will serve as the denominator for shareholder notification calculations under FCA rules.

Disclaimer*

Caspian Sunrise plc
02 December 2025
 

 

Caspian Sunrise PLC

("Caspian Sunrise" or the "Company")

 

Issue of shares

The Board of Caspian Sunrise is pleased to confirm that a total of 2,121,210 new ordinary Caspian Sunrise PLC shares have been issued credited as fully paid in respect of bonus payments to non-board members based on an issue price of 5p per share.

Application will be made for the New Shares to be admitted to trading on AIM, which is expected to occur on or around 5 December 2025 ("Admission"). The New Shares will rank pari passu in all respects with the Company's existing ordinary shares currently traded on AIM.

Following Admission, the Company's issued share capital will comprise 2,356,306,042 ordinary shares of 1 pence each. This number will represent the total voting rights in the Company and may be used by shareholders as the denominator for the calculation by which they can determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

Contacts:

 

Zeus

James Joyce

James Bavister

Andrew de Andrade

+44 (0) 203 829 5000

 

This announcement has been posted to:

www.caspiansunrise.com/investors

 

The person responsible for arranging the release of this announcement on behalf of the Company is Clive Carver, Chairman of the Company.

 

This announcement has been posted to:

www.caspiansunrise.com/investors

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings